Adinazolam
Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative, and more specifically, a triazolobenzodiazepine (TBZD). It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. Adinazolam was never FDA approved and never made available to the public market, however it has been sold as a designer drug.
Wikipage redirect
primaryTopic
Adinazolam
Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative, and more specifically, a triazolobenzodiazepine (TBZD). It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. Adinazolam was never FDA approved and never made available to the public market, however it has been sold as a designer drug.
has abstract
Adinazolam (marketed under the ...... been sold as a designer drug.
@en
L'adinazolam (commercialisé so ...... sédatives, et antidépressives.
@fr
ATC prefix
ATC suffix
CAS number
37115-32-5
ChEBI
DrugBank
FDA UNII code
KN08449444
IUPAC name
1-(8-Chloro-6-phenyl-4H-[1,2,4 ...... -1-yl)-N,N-dimethylmethanamine
@en
PubChem
thumbnail
Wikipage page ID
Wikipage revision ID
742,539,868
ChEMBL
ChemSpiderID
elimination half-life
legal CA
molecular weight
routes of administration
smiles
Clc3cc2\Cc4ccccc4
StdInChIKey
GJSLOMWRLALDCT-UHFFFAOYSA-N
verifiedrevid
477,242,623
Watchedfields
subject
comment
Adinazolam (marketed under the ...... been sold as a designer drug.
@en
L'adinazolam (commercialisé so ...... sédatives, et antidépressives.
@fr
label
Adinazolam
@en
Adinazolam
@fr